Komori
Noritsu Koki (7744) · PolicyDropped

“face the NEXT” and Multiple Long-Term Growth Areas

First written in FY2016. 12 of 20 entries say "Restated". Latest entry: FY2024.

20entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2020-Q3ReframedFY2020 – FY2021-Q1RestatedFY2023 – FY20242016: 320162017: 420172018: 420182019: 320192020: 420202021: 020212022: 020222023: 020232024: 120242025: 1
Same theme, other companies
“face the NEXT” and Multiple Long-Term Growth AreasA theme 19 companies write about · 0 as a headwind · 20 as a tailwind

The whole theme swung hardest in 2020: 1 of 11 companies on the "Worse" side.

0 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 19 companies compared. The sentences above are computed from all 19.
Full recordFilings, disclosures and news, newest first
  1. FY2024DroppedAnnual report

    「The Group has designated its core businesses as manufacturing (components and materials) and manufacturing (professional audio equipment-related).」

    The former "face the NEXT" framework and multiple long-term growth areas are no longer stated; the current business vision and strategy are organized around 2 manufacturing businesses as core businesses.
  2. FY2023RestatedAnnual report

    「Based on its business vision of "a business group that continues to create No. 1/Only 1 businesses," the Group is proceeding with the reorganization of its business portfolio.」

    The Group continues its current vision of being a business group that creates No. 1/Only 1 businesses, rather than the former "face the NEXT" brand statement, together with portfolio management.
  3. FY2021-Q1ReframedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, the Group worked in line with its medium-term management plan to reorganize its business portfolio and strengthen the earnings power and organizational capabilities of its core manufacturing and healthcare businesses.」

    The Group is moving from a framework of growing multiple business areas in parallel to one centered on manufacturing and healthcare as core businesses, portfolio restructuring, and strengthening both businesses' earnings power and organizational capabilities.
  4. FY2020ReframedAnnual report

    「The Company transferred the business companies other than its core businesses among its business segments and completed the reorganization into business segments comprising manufacturing and healthcare.」

    The Company says it has narrowed its business segments from multiple long-term growth areas to the core manufacturing and healthcare businesses and completed the portfolio restructuring.
  5. FY2020ReframedAnnual report

    「The Group operates in the manufacturing, healthcare, and senior life areas. In an era of continual change, it is reorganizing its business portfolio based on its business vision of "a business group that continues to create No. 1/Only 1 businesses," with the aim of creating businesses that are widely sought after and form part of society's infrastructure.」

    The former 5-area framework was reorganized around 3 business areas, manufacturing, healthcare, and senior life, together with business portfolio restructuring. The business vision is stated as "a business group that continues to create No. 1/Only 1 businesses."
  6. FY2020-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, the Group also continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of strengthening earnings power across 5 business areas.
  7. FY2020-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, the Group also continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of targeting 5 areas for long-term growth and earnings enhancement.
  8. FY2020-Q1RestatedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues strengthening earnings power across 5 areas.
  9. FY2019-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of strengthening earnings power across 5 business areas.
  10. FY2019-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of strengthening earnings power across 5 business areas.
  11. FY2019-Q1RestatedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of targeting 5 business areas for long-term growth and earnings enhancement.
  12. FY2018ReframedAnnual report

    「The Group has adopted "face the NEXT" as its brand statement and operates in the manufacturing, healthcare, drug discovery, senior life, and agri-food areas. Within this framework, manufacturing is positioned as a core area, while the dental and medical-institution support businesses within senior life and healthcare are stable-income areas. The Group is pursuing various initiatives to further strengthen earnings power by investing funds generated through the stable growth of these areas in the medical information, biotechnology, and digital areas, which are its medium- to long-term growth areas.」

    While maintaining "face the NEXT" and the 5 business areas, the Group reorganized their roles into core, stable-income, and medium- to long-term growth areas, with funds from the stable areas invested in medical information, biotechnology, and digital.
  13. FY2018-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of strengthening earnings power across 5 areas.
  14. FY2018-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of strengthening earnings power across 5 business areas.
  15. FY2018-Q1RestatedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, healthcare, drug discovery, senior life, and agri-food areas.」

    The Group continues its policy of targeting the former 5 areas for strengthening earnings power.
  16. FY2017ReframedAnnual report

    「The Company has been actively transforming its business portfolio, including the transfer of its imaging business, which was its founding business, in February 2016. Beginning in the fiscal year ending March 2017, it launched NK2.0, designated biotechnology, healthcare information, and digital as growth areas, and aims to build a new group structure.」

    In addition to the previous “face the NEXT” framework and five areas, the Group has clarified its focus on biotechnology, healthcare information, and digital as growth areas under NK2.0.
  17. FY2017-Q3SoftenedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in the manufacturing, food, healthcare, and senior life areas.」

    The environment area is no longer included among the five areas previously identified, leaving four areas targeted for strengthening earnings power. This change followed the transfer of the environment segment’s sole business.
  18. FY2017-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, environment, food, healthcare, and senior life areas.」

    The Group continues its policy of strengthening earnings power in the five long-term growth areas.
  19. FY2017-Q1RestatedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, the Group continued working to strengthen earnings power in each of the manufacturing, environment, food, healthcare, and senior life areas.」

    The Group continues to target five areas for strengthening earnings power.
  20. FY2016First statedAnnual report

    「The Group has adopted “face the NEXT” as its brand statement, designated manufacturing, the environment, food, healthcare, and senior life as long-term growth areas, identified further strengthening earnings power as a key challenge, and is pursuing various initiatives.」

    The Group positions five business areas as long-term growth areas and regards strengthening earnings power as a key challenge.
Moved together

"Building a portfolio that includes new growth areas" moved the same way as this thread, in the same document, in 5 of its 19 moves.

544222★123456
  1. ★This thread
  2. 1Building a portfolio that includes new growth areas5×
  3. 2Overseas revenue and foreign-exchange fluctuations4×
  4. 3Building a stable growth platform by expanding businesses across five areas4×
  5. 4Risk of breaching borrowings and financial covenants2×
  6. 5¥10 Billion in Business Profit2×
  7. 6Strengthening Product Development Capabilities for Seniors2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Noritsu Koki yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
“face the NEXT” and Multiple Long-Term Growth Areas | Noritsu Koki Co.,Ltd. (7744) | Komori